EHS
EHS

Biologics vs Small Molecule Drugs for UC: Which Agent Emerged on Top?



(MedPage Today) — One Janus kinase (JAK) inhibitor was significantly superior to all other agents for inducing clinical remission in patients with moderate-to-severe ulcerative colitis (UC), but also ranked highest for adverse events, a network…

Source link

EHS
Back to top button